Korean digital health company LifeSemantics has obtained the first approval for an AI-powered solution for skin cancer diagnosis in South Korea.
The company received regulatory clearance from the Ministry of Food and Drug Safety for canofyMD SCAI four months after its application.
The mobile AI technology was developed through the Doctor Answer 2.0 project, which has gathered 30 hospitals and 19...
